nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyridostigmine—Abnormal behaviour—Varenicline—nicotine dependence	0.102	0.106	CcSEcCtD
Pyridostigmine—Depressed mood—Varenicline—nicotine dependence	0.0853	0.0882	CcSEcCtD
Pyridostigmine—Delusion—Varenicline—nicotine dependence	0.0539	0.0557	CcSEcCtD
Pyridostigmine—Chest discomfort—Varenicline—nicotine dependence	0.0431	0.0445	CcSEcCtD
Pyridostigmine—Lacrimation increased—Varenicline—nicotine dependence	0.0414	0.0428	CcSEcCtD
Pyridostigmine—Blood pressure increased—Varenicline—nicotine dependence	0.0382	0.0394	CcSEcCtD
Pyridostigmine—Salivary hypersecretion—Varenicline—nicotine dependence	0.0371	0.0383	CcSEcCtD
Pyridostigmine—Hypertonia—Varenicline—nicotine dependence	0.0334	0.0346	CcSEcCtD
Pyridostigmine—Eye pain—Varenicline—nicotine dependence	0.0307	0.0317	CcSEcCtD
Pyridostigmine—Lethargy—Varenicline—nicotine dependence	0.0283	0.0292	CcSEcCtD
Pyridostigmine—Dry skin—Varenicline—nicotine dependence	0.0254	0.0262	CcSEcCtD
Pyridostigmine—Cramp muscle—Varenicline—nicotine dependence	0.0249	0.0258	CcSEcCtD
Pyridostigmine—Abdominal distension—Varenicline—nicotine dependence	0.0241	0.0249	CcSEcCtD
Pyridostigmine—Asthma—Varenicline—nicotine dependence	0.0239	0.0247	CcSEcCtD
Pyridostigmine—Bronchitis—Varenicline—nicotine dependence	0.023	0.0238	CcSEcCtD
Pyridostigmine—Pollakiuria—Varenicline—nicotine dependence	0.0221	0.0228	CcSEcCtD
Pyridostigmine—Epistaxis—Varenicline—nicotine dependence	0.0201	0.0208	CcSEcCtD
Pyridostigmine—Bradycardia—Varenicline—nicotine dependence	0.0195	0.0202	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Varenicline—nicotine dependence	0.0191	0.0197	CcSEcCtD
Pyridostigmine—Flatulence—Varenicline—nicotine dependence	0.0164	0.017	CcSEcCtD
Pyridostigmine—Muscle spasms—Varenicline—nicotine dependence	0.016	0.0166	CcSEcCtD
Pyridostigmine—Agitation—Varenicline—nicotine dependence	0.0153	0.0158	CcSEcCtD
Pyridostigmine—Vertigo—Varenicline—nicotine dependence	0.015	0.0155	CcSEcCtD
Pyridostigmine—Loss of consciousness—Varenicline—nicotine dependence	0.0147	0.0151	CcSEcCtD
Pyridostigmine—Convulsion—Varenicline—nicotine dependence	0.0145	0.0149	CcSEcCtD
Pyridostigmine—Myalgia—Varenicline—nicotine dependence	0.0142	0.0147	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Varenicline—nicotine dependence	0.0132	0.0136	CcSEcCtD
Pyridostigmine—Hypotension—Varenicline—nicotine dependence	0.0127	0.0131	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.0124	0.0128	CcSEcCtD
Pyridostigmine—Somnolence—Varenicline—nicotine dependence	0.0121	0.0125	CcSEcCtD
Pyridostigmine—Feeling abnormal—Varenicline—nicotine dependence	0.0112	0.0116	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Varenicline—nicotine dependence	0.0111	0.0115	CcSEcCtD
Pyridostigmine—Urticaria—Varenicline—nicotine dependence	0.0108	0.0112	CcSEcCtD
Pyridostigmine—Abdominal pain—Varenicline—nicotine dependence	0.0108	0.0111	CcSEcCtD
Pyridostigmine—Hypersensitivity—Varenicline—nicotine dependence	0.01	0.0104	CcSEcCtD
Pyridostigmine—Asthenia—Varenicline—nicotine dependence	0.00977	0.0101	CcSEcCtD
Pyridostigmine—Diarrhoea—Varenicline—nicotine dependence	0.00931	0.00962	CcSEcCtD
Pyridostigmine—Vomiting—Varenicline—nicotine dependence	0.00866	0.00894	CcSEcCtD
Pyridostigmine—Rash—Varenicline—nicotine dependence	0.00858	0.00887	CcSEcCtD
Pyridostigmine—Dermatitis—Varenicline—nicotine dependence	0.00858	0.00886	CcSEcCtD
Pyridostigmine—Headache—Varenicline—nicotine dependence	0.00853	0.00881	CcSEcCtD
Pyridostigmine—Nausea—Varenicline—nicotine dependence	0.00809	0.00835	CcSEcCtD
Pyridostigmine—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00177	0.0554	CbGpPWpGaD
Pyridostigmine—ACHE—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00153	0.0478	CbGpPWpGaD
Pyridostigmine—ACHE—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00145	0.0453	CbGpPWpGaD
Pyridostigmine—BCHE—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00136	0.0426	CbGpPWpGaD
Pyridostigmine—BCHE—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00129	0.0404	CbGpPWpGaD
Pyridostigmine—ACHE—Neuronal System—CHRNB3—nicotine dependence	0.00117	0.0366	CbGpPWpGaD
Pyridostigmine—ACHE—Neuronal System—CHRNA6—nicotine dependence	0.00111	0.0347	CbGpPWpGaD
Pyridostigmine—ACHE—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00105	0.0328	CbGpPWpGaD
Pyridostigmine—BCHE—Neuronal System—CHRNB3—nicotine dependence	0.00104	0.0327	CbGpPWpGaD
Pyridostigmine—ACHE—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.001	0.0314	CbGpPWpGaD
Pyridostigmine—BCHE—Neuronal System—CHRNA6—nicotine dependence	0.000989	0.031	CbGpPWpGaD
Pyridostigmine—BCHE—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.000933	0.0292	CbGpPWpGaD
Pyridostigmine—ACHE—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.000933	0.0292	CbGpPWpGaD
Pyridostigmine—BCHE—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.000895	0.028	CbGpPWpGaD
Pyridostigmine—BCHE—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.000832	0.026	CbGpPWpGaD
Pyridostigmine—ACHE—Neuronal System—GABRA4—nicotine dependence	0.000802	0.0251	CbGpPWpGaD
Pyridostigmine—ACHE—Neuronal System—CHRNB4—nicotine dependence	0.000769	0.0241	CbGpPWpGaD
Pyridostigmine—ACHE—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00076	0.0238	CbGpPWpGaD
Pyridostigmine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000735	0.023	CbGpPWpGaD
Pyridostigmine—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000726	0.0227	CbGpPWpGaD
Pyridostigmine—BCHE—Neuronal System—GABRA4—nicotine dependence	0.000715	0.0224	CbGpPWpGaD
Pyridostigmine—ACHE—Neuronal System—CHRNA5—nicotine dependence	0.000715	0.0224	CbGpPWpGaD
Pyridostigmine—BCHE—Neuronal System—CHRNB4—nicotine dependence	0.000686	0.0215	CbGpPWpGaD
Pyridostigmine—BCHE—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000678	0.0212	CbGpPWpGaD
Pyridostigmine—ACHE—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000669	0.021	CbGpPWpGaD
Pyridostigmine—BCHE—Neuronal System—CHRNA5—nicotine dependence	0.000637	0.02	CbGpPWpGaD
Pyridostigmine—ACHE—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000608	0.019	CbGpPWpGaD
Pyridostigmine—BCHE—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000597	0.0187	CbGpPWpGaD
Pyridostigmine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000596	0.0187	CbGpPWpGaD
Pyridostigmine—ACHE—Neuronal System—CHRNA3—nicotine dependence	0.000583	0.0182	CbGpPWpGaD
Pyridostigmine—BCHE—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000542	0.017	CbGpPWpGaD
Pyridostigmine—BCHE—Neuronal System—CHRNA3—nicotine dependence	0.00052	0.0163	CbGpPWpGaD
Pyridostigmine—ACHE—Neuronal System—CHRNB2—nicotine dependence	0.000513	0.0161	CbGpPWpGaD
Pyridostigmine—ACHE—Neuronal System—CHRNA4—nicotine dependence	0.000466	0.0146	CbGpPWpGaD
Pyridostigmine—BCHE—Neuronal System—CHRNB2—nicotine dependence	0.000458	0.0143	CbGpPWpGaD
Pyridostigmine—BCHE—Neuronal System—CHRNA4—nicotine dependence	0.000415	0.013	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000336	0.0105	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000317	0.00991	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000312	0.00977	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CYP2A7—nicotine dependence	0.000202	0.00632	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CYP2A7—nicotine dependence	0.00018	0.00564	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CYP2A7—nicotine dependence	5.41e-05	0.00169	CbGpPWpGaD
